Average Co-Inventor Count = 2.86
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. National Institutes of Health, a Component of the US Dept. of Health & Human Services (14 from 3,435 patents)
2. Voyager Therapeutics, Inc. (8 from 41 patents)
3. University of Massachusetts (2 from 1,551 patents)
4. Institut National De La Sante Et De La Recherche Medicale (1 from 1,743 patents)
5. University of Iowa Research Foundation (1 from 902 patents)
6. Children's Medical Research Institute (1 from 7 patents)
7. The Sydney Children's Hospitals Network (randwick and Westmead) (incorporating the Royal Alexandra Hospital for Children) (1 from 5 patents)
8. The Sydney Children's Hospitals Network (0 patent)
22 patents:
1. 12252703 - Closed-ended linear duplex DNA for non-viral gene transfer
2. 12180500 - Chimeric capsids
3. 11975056 - AADC polynucleotides for the treatment of Parkinson's disease
4. 11697825 - Compositions and methods for the production of scAAV
5. 11549125 - Closed-ended, linear, duplex adenoassociated virus DNA, and uses thereof
6. 11066679 - Closed-ended linear duplex DNA for non-viral gene transfer
7. 11027000 - AADC polynucleotides for the treatment of Parkinson's disease
8. 10882886 - Adeno-associated virus polynucleotides, polypeptides and virions
9. 10577627 - Chimeric capsids
10. 10335466 - AADC polynucleotides for the treatment of parkinson's disease
11. 9598703 - Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery
12. 8846389 - AAV4 vector and uses thereof
13. 8507267 - AAV4 vector and uses thereof
14. 7718424 - AAV4 vector and uses thereof
15. 7479554 - AAV5 nucleic acids